NEWS

NEWSNEWS

23
Mar

Dr. Luis Serrano hosts a special two-day symposium to commemorate the occasion

INSTITUCIONAL
16
Mar

yuri and CRG sign first worldwide agreement between a commercial space biotech company and a biomedical research institute 

EMPRESA
13
Mar

Honorary Award bestowed by the Catalan Association of Telecommunications and the Official College of Computer Engineering of Catalonia

DISTINCIONS I PREMIS
07
Mar

New mechanism found which can be exploited to prevent or heal damage to the heart 

RECERCA
24
Feb

The facility will house two high-end electron microscopes which determine protein structures and materials at the atomic level

INSTITUCIONAL
16
Feb

CRG researcher is one of fourteen individuals recognised by the city’s government

DISTINCIONS I PREMIS
13
Feb

Atlas of circadian and circannual variation reveals therapeutic targets which could benefit from different doses depending on time of day and season

RECERCA
09
Feb
The image shows pancreatic islets in mice, specialised tissues that host beta cells. On the left, a healthy pancreatic islet is shown with its typical morphology with alpha cells in the periphery and beta cells in the core of the islet. On the right, mice with a mutation in Srrm3 that knock out the cells’ ability to regulate microexon inclusion results in islets with altered morphology and cell identity. This and other functional alterations ultimately impacts on the release of insulin. Jonas Juan Mateu

Microexons constitute new potential therapeutic targets for treating diabetes

RECERCA
31
Jan

Elvan Böke’s research group receives a 2-million-euro European Research Consolidator grant

FINANçAMENT
19
Jan
This shows a cross-section of a mouse lung infected with Pseudonomas aeruginosa. The mouse was treated with a version of Mycoplasma pneumoniae that could not produce therapeutic molecules, resulting in severe pneumoniae. This is characterised by massive infiltration of inflammatory cells into the alveolar septa, resulting in loss of air in the alveoli. Credit: Rocco Mazzolini/CRG

Study showcases synthetic biology's potential in transforming treatment of human disease

RECERCA

Pages